Reviva Pharmaceuticals Holdings Inc.

27/08/2024 | Press release | Distributed by Public on 27/08/2024 12:08

Reviva to Host Virtual KOL Event to Discuss Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia on September 4, 2024 Earnings Release